Ambulatory Infusion Pumps used in Pain Management Business by InfuSystem to Receive Separate Payment Under NOPAIN Act Starting January 1, 2026 [Yahoo! Finance]
Ambulatory Infusion Pumps used in Pain Management Business by InfuSystem to Receive Separate Payment Under NOPAIN Act Starting January 1, 2026
InfuSystem to Participate at 16th Annual Craig-Hallum Alpha Select Conference on November 18, 2025
InfuSystem Holdings: Riding On The Oncology Market Opportunity [Seeking Alpha]
InfuSystem (NYSE:INFU) was given a new $14.00 price target on by analysts at Roth Capital. They now have a "buy" rating on the stock.